2024-03-28T19:03:16Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_EC7F78FF6FBA
2024-03-23T03:10:04Z
serval:BIB_EC7F78FF6FBA
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.
10.1111/j.1750-3639.2008.00153.x
18400046
000259146700007
Preusser
M.
author
Charles Janzer
R.
author
Felsberg
J.
author
Reifenberger
G.
author
Hamou
M.F.
author
Diserens
A.C.
author
Stupp
R.
author
Gorlia
T.
author
Marosi
C.
author
Heinzl
H.
author
Hainfellner
J.A.
author
Hegi
M.
author
article
2008
Brain Pathology
1015-6305
journal
18
4
520-532
Adult
Aged
Antibodies
Antibody Specificity
Brain Neoplasms
Cohort Studies
DNA Methylation
DNA Modification Methylases
DNA Repair Enzymes
Diagnosis, Differential
Glioblastoma
Humans
Immunohistochemistry
Middle Aged
Observer Variation
Predictive Value of Tests
Promoter Regions, Genetic
Prospective Studies
Reproducibility of Results
Survival Rate
Tumor Markers, Biological
Tumor Suppressor Proteins
eng
60_published
peer-reviewed